---
title: "Roche expands Boston presence with new research center — biotech roundup"
id: "stat-news-0-stat-roche-expands-its-boston-footprint-with-new-research-center"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-roche-expands-its-boston-footprint-with-new-research-center"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/?utm_campaign=rss"
published_at: "2026-09-18T13:42:29.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Roche expands Boston presence with new research center — biotech roundup
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-roche-expands-its-boston-footprint-with-new-research-center
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/?utm_campaign=rss)
- **Published At:** 2026-09-18T13:42:29.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- STAT reported that Roche is expanding its **Boston** footprint with a new research center; the headline frames this as a major local development in biotech. - The STAT piece is a roundup that also highlights a newly approved **gene therapy** for **Sanfilippo syndrome**, a rare pediatric disease, and frames that approval as a significant moment for families and the field. - The article notes reporting on a rare gene variant associated with markedly increased lung cancer risk in non-smokers, signaling an important research finding for cancer risk stratification. - It also previews an upcoming confirmation hearing for the nominee to lead the **FDA**, indicating political and regulatory developments relevant to drug development and oversight. - The item is authored by Meghana Keshavan, Adam Feuerstein, and Margaret Manto and dated Sept. 18, 2026. - The story is published as a STAT+ exclusive; the full article content and detailed reporting are behind the STAT+ subscriber paywall. - Source text includes an author reflection about the long timeline to develop therapies for Sanfilippo and a personal note on losses families face while waiting for treatments. - The public-facing excerpt on the STAT site provides headlines and topic tags (biotechnology, drug development, drug prices, research) but does not report detailed specifics of Roche’s Boston expansion or the precise data underlying the other items in the excerpt. - Because the article is subscriber-only, specific operational details, site location, headcount or strategic aims for Roche’s new center, and granular data about the gene-variant finding or the FDA nominee were not reported in the accessible excerpt.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [RFK Jr.](https://www.statnews.com/topic/rfk-jr/) [Cancer](https://www.statnews.com/topic/cancer/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Newsletter[The Readout](https://www.statnews.com/category/readout-newsletter/) # Roche expands its Boston footprint with new research center ## A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/?utm_campaign=rss) ![gantenerumab Alzheimer's disease Roche](https://www.statnews.com/wp-content/uploads/2022/10/GettyImages-1211395654-645x645.jpg) Sebastien Bozon/AFP via Getty Images ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2026/08/Margaret-Manto-avatar-round-80x80.png) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/), [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), and [Margaret Manto](https://www.statnews.com/staff/margaret-manto/) Sept. 18, 2026 ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) 1. [](https://x.com/megkesh "X") meghana.keshavan@statnews.com Meghana Keshavan covers biotech and contributes to [The Readout newsletter](https://www.statnews.com/signup/readout/). ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") adam.feuerstein@statnews.com Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. ![](https://www.statnews.com/wp-content/uploads/2026/08/Margaret-Manto-avatar-round-80x80.png) [Margaret Manto](https://www.statnews.com/staff/margaret-manto/) 1. [](https://www.linkedin.com/in/margaret-manto/ "Linkedin") 2. [](https://x.com/MargaretManto "X") margaret.manto@statnews.com Margaret is a Washington correspondent covering the Food and Drug Administration and other federal health agencies. Reach her on Signal at margaretmanto.61. _Want to stay on top of the science and politics driving biotech today?[Sign up](https://www.statnews.com/signup/readout/) to get our biotech newsletter in your inbox._ Today, we discuss the first gene therapy approval for Sanfilippo syndrome, learn of a rare gene variant linked to dramatically heightened lung cancer risk in non-smokers, and look ahead toward the confirmation hearing for the nominee to lead the FDA. Advertisement About the Sanfilipo approval: I first [wrote about the effort](https://www.statnews.com/2016/12/29/sanfilippo-rare-disease/) to develop a therapy a decade ago. I get melancholy sometimes when I think of how many kids have declined or died before their families can get cutting-edge therapies approved for children who are not their own. But science takes time, and biotech can produce a better tomorrow, no? STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [Drug prices](https://www.statnews.com/topic/drug-prices/), [research](https://www.statnews.com/topic/research/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/meghana-k-avatar-small2-80x80.png) [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) 1. [](https://x.com/megkesh "X") 2. Biotech Correspondent 1. [](https://x.com/megkesh "X") 2. Meghana Keshavan covers biotech and contributes to [The Readout newsletter](https://www.statnews.com/signup/readout/). 2. ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") 2. Senior Writer, Biotech 1. [](https://x.com/adamfeuerstein "X") 2. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/Margaret-Manto-avatar-round-80x80.png) [Margaret Manto](https://www.statnews.com/staff/margaret-manto/) 1. [](https://x.com/MargaretManto "X") 2. [](https://bsky.app/profile/margaretmanto.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/margaret-manto/ "Linkedin") Washington Correspondent 1. [](https://x.com/MargaretManto "X") 2. [](https://bsky.app/profile/margaretmanto.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/margaret-manto/ "Linkedin") Margaret is a Washington correspondent covering the Food and Drug Administration and other federal health agencies. Reach her on Signal at margaretmanto.61. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_595817060-80x80.jpeg) [Kennedy announces new effort to speed up autism diagnoses](https://www.statnews.com/2026/09/17/kennedy-announces-new-research-fund-to-improve-autism-diagnoses/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-17-at-12.44.49-PM-80x80.jpg) [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://www.statnews.com/2026/09/17/rfk-jr-anti-vaccination-activism-childrens-health-defense-conference/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2289879326-80x80.jpg) [Kennedy moves to revive preventive services panel with new members, after months of vacancies](https://www.statnews.com/2026/09/17/kennedy-names-eight-new-members-uspstf-task-force/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/Eliza-treated-with-Gene-therapy-2016-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_419260729_Editorial_Use_Only-80x80.jpeg) [New lawsuit argues NIH violated First Amendment rights of grant applicants](https://www.statnews.com/2026/09/16/lawsuit-argues-nih-violated-researcher-first-amendment-rights-aclu/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-10-at-11.16.19-AM-e1789064257681-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) 3. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Sellas immunotherapy study, long delayed, will end in failure](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) 4. ![](https://www.statnews.com/wp-content/uploads/2016/09/Infusion_AP_328963423903-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scholar Rock wins FDA approval for first drug to target SMA muscle loss](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2292889136-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicare to expand its pilot that pays for technology to manage chronic diseases](https://www.statnews.com/2026/09/15/medicare-access-chronic-care-management-tech-pilot-expanding/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease ](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: New startup to test psychedelic-like drug against Parkinson’s symptom ](https://www.statnew
## Related Clinical Research

- [How $500 Checks Illustrate Republican Health Policy and the GLP-1 Prescription Wave](https://medichelpline.com/clinical-feed/stat-news-1-stat-how-500-explains-republican-health-policy-and-the-glp-1-rx-wave.md)
- [Analysis: Why the GOP’s $50 Billion Rural Health Fund Falls Short for Hospitals](https://medichelpline.com/clinical-feed/stat-news-3-the-gop-s-50-billion-rural-health-fund-is-coming-up-short-hospital-leaders-say.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Daraxonrasib shows activity in RAS‑mutant NSCLC after FDA approval in pancreatic cancer](https://medichelpline.com/clinical-feed/medical-news-today-0-pancreatic-cancer-drug-may-also-help-fight-treatment-resistant-lung-cancer.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.